Free Trial
OTC:AKBLF

ALK-Abelló A/S (AKBLF) Stock Price, News & Analysis

ALK-Abelló A/S logo
$24.00
0.00 (0.00%)
(As of 11/4/2024 ET)

About ALK-Abelló A/S Stock (OTC:AKBLF)

Key Stats

Today's Range
$24.00
$24.00
50-Day Range
$21.68
$27.03
52-Week Range
$13.25
$27.03
Volume
N/A
Average Volume
648 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food. It also provides consumer healthcare solution, which include Digital eco-system, a platform which connect and engages with allergy sufferers in the disease journey through tools and e-commerce offerings that supports, guidance and relief, and smoothing the path to allergy immunotherapy treatment. In addition, the company offers diagnostic allergy solutions through testing by skin prick test or blood test; and emergency treatment, such as intra-muscular injection of adrenaline for the treatment of acute life-threatening allergic reactions, including Anaphylaxis. The company has a collaboration with Torii Pharmaceutical Co., Ltd. to develop, market and distribute allergy immunotherapy tablet for the treatment of grass pollen allergy. ALK-Abelló A/S was founded in 1923 and is headquartered in Horsholm, Denmark.

Receive AKBLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALK-Abelló A/S and its competitors with MarketBeat's FREE daily newsletter.

AKBLF Stock News Headlines

DPBSF Dampskibsselskabet Norden A/S
AKBLF ALK-Abelló A/S
This company will win the AI race
Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.
ALK upgrades its full-year revenue and earnings outlook
Alaska Air (ALK) Receives a Buy from Seaport Global
See More Headlines

AKBLF Stock Analysis - Frequently Asked Questions

ALK-Abelló A/S's stock was trading at $13.25 at the beginning of 2024. Since then, AKBLF stock has increased by 81.1% and is now trading at $24.0014.
View the best growth stocks for 2024 here
.

Shares of AKBLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
2,824
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (OTC:AKBLF) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners